Greg M Thurber (Greg Thurber)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 32

Top Venues

Bioconjugate chemistry

Science advances

Proceedings of the National Academy of Sciences of the United States of America

bioRxiv : the preprint server for biology

University of Michigan

Massachusetts Institute of Technology (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Michigan

United States

Assistant Professor :: Chemical Engineering and Biomedical Engineering

Education History

Massachusetts Institute of Technology

United States

PHD :: Chemical Engineering

Pennsylvania State University

United States

BSC :: Chemical Engineering

Publications

Anna Kopp, Shujun Dong, Hyeyoung Kwon, Tiexin Wang, Alec A Desai, Jennifer J Linderman, Peter M Tessier, Greg M Thurber
In vivo Auto-tuning of Antibody-Drug Conjugate Delivery for Effective Immunotherapy using High-Avidity, Low-Affinity Antibodies. bioRxiv : the preprint server for biology (2024)
Baron Rubahamya, Shujun Dong, Greg M Thurber
Clinical translation of antibody drug conjugate dosing in solid tumors from preclinical mouse data. Science advances 10 (22) (2024)
Anna Kopp, Shujun Dong, Hyeyoung Kwon, Tiexin Wang, Alec A Desai, Jennifer J Linderman, Peter M Tessier, Greg M Thurber
In vivo Auto-tuning of Antibody-Drug Conjugate Delivery for Effective Immunotherapy using High-Avidity, Low-Affinity Antibodies. bioRxiv : the preprint server for biology (2024)
Anna Kopp, Jiakun Guan, Colette Johnston, Steven Vance, James Legg, Laurie Galson-Holt, Greg M Thurber
Design of Crosslinking Antibodies For T-Cell Activation: Experimental and Computational Analysis of PD-1/CD137 Bispecific Agents. The AAPS journal 26 (4) (2024)
Marshall Case, Matthew Smith, Jordan Vinh, Greg M Thurber
Machine learning to predict continuous protein properties from binary cell sorting data and map unseen sequence space. Proceedings of the National Academy of Sciences of the United States of America 121 (11) (2024)
Marshall Case, Matthew Smith, Jordan Vinh, Greg M Thurber
Machine learning to predict continuous protein properties from binary cell sorting data and map unseen sequence space. Proceedings of the National Academy of Sciences of the United States of America 121 (11) (2024)
Baron Rubahamya, Shujun Dong, Greg M Thurber
Clinical translation of antibody drug conjugate dosing in solid tumors from preclinical mouse data. Science advances 10 (22) (2024)
Marshall Case, Matthew Smith, Jordan Vinh, Greg M Thurber
Machine learning to predict continuous protein properties from binary cell sorting data and map unseen sequence space. Proceedings of the National Academy of Sciences of the United States of America 121 (11) (2024)
Baron Rubahamya, Shujun Dong, Greg M Thurber
Clinical translation of antibody drug conjugate dosing in solid tumors from preclinical mouse data. Science advances 10 (22) (2024)
Baron Rubahamya, Shujun Dong, Greg M Thurber
Clinical translation of antibody drug conjugate dosing in solid tumors from preclinical mouse data. Science advances 10 (22) (2024)
Anna Kopp, Jiakun Guan, Colette Johnston, Steven Vance, James Legg, Laurie Galson-Holt, Greg M Thurber
Design of Crosslinking Antibodies For T-Cell Activation: Experimental and Computational Analysis of PD-1/CD137 Bispecific Agents. The AAPS journal 26 (4) (2024)
Marshall Case, Matthew Smith, Jordan Vinh, Greg M Thurber
Machine learning to predict continuous protein properties from binary cell sorting data and map unseen sequence space. Proceedings of the National Academy of Sciences of the United States of America 121 (11) (2024)
Anna Kopp, Jiakun Guan, Colette Johnston, Steven Vance, James Legg, Laurie Galson-Holt, Greg M Thurber
Design of Crosslinking Antibodies For T-Cell Activation: Experimental and Computational Analysis of PD-1/CD137 Bispecific Agents. The AAPS journal 26 (4) (2024)
Anna Kopp, Shujun Dong, Hyeyoung Kwon, Tiexin Wang, Alec A Desai, Jennifer J Linderman, Peter M Tessier, Greg M Thurber
In vivo Auto-tuning of Antibody-Drug Conjugate Delivery for Effective Immunotherapy using High-Avidity, Low-Affinity Antibodies. bioRxiv : the preprint server for biology (2024)
Laureen de Bever, Sorraya Popal, Jord van Schaik, Baron Rubahamya, Floris L van Delft, Greg M Thurber, Sander S van Berkel
Generation of DAR1 Antibody-Drug Conjugates for Ultrapotent Payloads Using Tailored GlycoConnect Technology. Bioconjugate chemistry (2023)
Eshita Khera, Jaeyeon Kim, Andrew Stein, Matt Ratanapanichkich, Greg M Thurber
Mechanistically weighted metric to predict in vivo antibody-receptor occupancy: An analytical approach . The Journal of pharmacology and experimental therapeutics (2023)
Laureen de Bever, Sorraya Popal, Jord van Schaik, Baron Rubahamya, Floris L van Delft, Greg M Thurber, Sander S van Berkel
Generation of DAR1 Antibody-Drug Conjugates for Ultrapotent Payloads Using Tailored GlycoConnect Technology. Bioconjugate chemistry 34 (3) (2023)
Ian Nessler, Baron Rubahamya, Anna Kopp, Scott Hofsess, Thomas M Cardillo, Nalini Sathyanarayan, Jennifer Donnell, Serengulam V Govindan, Greg M Thurber
Improving Intracellular Delivery of an Antibody-Drug Conjugate Targeting Carcinoembryonic Antigen Increases Efficacy at Clinically Relevant Doses In Vivo. Molecular cancer therapeutics (2023)
Laureen de Bever, Sorraya Popal, Jord van Schaik, Baron Rubahamya, Floris L van Delft, Greg M Thurber, Sander S van Berkel
Generation of DAR1 Antibody-Drug Conjugates for Ultrapotent Payloads Using Tailored GlycoConnect Technology. Bioconjugate chemistry 34 (3) (2023)
Laureen de Bever, Sorraya Popal, Jord van Schaik, Baron Rubahamya, Floris L van Delft, Greg M Thurber, Sander S van Berkel
Generation of DAR1 Antibody-Drug Conjugates for Ultrapotent Payloads Using Tailored GlycoConnect Technology. Bioconjugate chemistry 34 (3) (2023)
Laureen de Bever, Sorraya Popal, Jord van Schaik, Baron Rubahamya, Floris L van Delft, Greg M Thurber, Sander S van Berkel
Generation of DAR1 Antibody-Drug Conjugates for Ultrapotent Payloads Using Tailored GlycoConnect Technology. Bioconjugate chemistry 34 (3) (2023)
Laureen de Bever, Sorraya Popal, Jord van Schaik, Baron Rubahamya, Floris L van Delft, Greg M Thurber, Sander S van Berkel
Generation of DAR1 Antibody-Drug Conjugates for Ultrapotent Payloads Using Tailored GlycoConnect Technology. Bioconjugate chemistry 34 (3) (2023)
Marshall Case, Tejas Navaratna, Jordan Vinh, Greg M Thurber
Rapid Evaluation of Staple Placement in Stabilized α Helices Using Bacterial Surface Display. ACS chemical biology (2023)
Laureen de Bever, Sorraya Popal, Jord van Schaik, Baron Rubahamya, Floris L van Delft, Greg M Thurber, Sander S van Berkel
Generation of DAR1 Antibody-Drug Conjugates for Ultrapotent Payloads Using Tailored GlycoConnect Technology. Bioconjugate chemistry 34 (3) (2023)
Anna Kopp, Scott Hofsess, Thomas M Cardillo, Serengulam V Govindan, Jennifer Donnell, Greg M Thurber
Antibody Drug Conjugate Sacituzumab Govitecan Drives Efficient Tissue Penetration and Rapid Intracellular Drug Release. Molecular cancer therapeutics (2022)
Bruna Menezes, Jennifer J Linderman, Greg M Thurber
Simulating the Selection of Resistant Cells with Bystander Killing and Antibody Coadministration in Heterogeneous HER2 Positive Tumors. Drug metabolism and disposition: the biological fate of chemicals (2021)
Guolan Lu, Naoki Nishio, Nynke S van den Berg, Brock A Martin, Shayan Fakurnejad, Stan van Keulen, Alexander D Colevas, Greg M Thurber, Eben L Rosenthal
Co-administered antibody improves penetration of antibody-dye conjugate into human cancers with implications for antibody-drug conjugates. Nature communications 11 (1) (2020)
Tejas Navaratna, Lydia Atangcho, Mukesh Mahajan, Vivekanandan Subramanian, Marshall Case, Andrew Min, Daniel Tresnak, Greg M Thurber
Directed Evolution Using Stabilized Bacterial Peptide Display. Journal of the American Chemical Society 142 (4) (2020)
Eshita Khera, Greg M Thurber
Pharmacokinetic and Immunological Considerations for Expanding the Therapeutic Window of Next-Generation Antibody-Drug Conjugates. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 32 (5) (2019)
Sumit Bhatnagar, Eshita Khera, Jianshan Liao, Victoria Eniola, Yongjun Hu, David E Smith, Greg M Thurber
Oral and Subcutaneous Administration of a Near-Infrared Fluorescent Molecular Imaging Agent Detects Inflammation in a Mouse Model of Rheumatoid Arthritis. Scientific reports 9 (1) (2019)
Sumit Bhatnagar, Kirti Dhingra Verma, Yongjun Hu, Eshita Khera, Aaron Priluck, David E Smith, Greg M Thurber
Oral Administration and Detection of a Near-Infrared Molecular Imaging Agent in an Orthotopic Mouse Model for Breast Cancer Screening. Molecular pharmaceutics 15 (5) (2018)
Cornelius Cilliers, Ian Nessler, Nikolas Christodolu, Greg M Thurber
Tracking Antibody Distribution with Near-Infrared Fluorescent Dyes: Impact of Dye Structure and Degree of Labeling on Plasma Clearance. Molecular pharmaceutics 14 (5) (2017)

Greg M Thurber.css-eqlu8i{font-size:small;padding-left:4px;} (Greg Thurber)

Publication Activity (10 Years)

Top Topics

Top Venues

Greg M Thurber (Greg Thurber)